Click on headlines below to download research
Thrace delivered another strong profit contribution in Q3, even after the expected slowdown in sales volumes to the medical subsector. This ongoing sector…
Thrace continued to successfully service high medical sector demand and support customers elsewhere in the face of input cost pressures in H121. Cash generation…
Record FY20 and Q121 results were founded upon Thrace’s strategic investment programme since 2015, reorienting the business towards higher-value…